Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Large-Scale Screening of Nanomaterial Toxicity and Activity

Abstract:
As researchers develop an ever-expanding toolkit of nanoparticles for use as drug and imaging agent delivery vehicles, there is a growing need to understand how a given nanoparticle's physical and chemical properties affect biological activity and toxicity. Now, two researchers working independently of one another have develop new methods for measuring the biological activity of nanomaterials in a highly systematic manner that enable them to draw important insights about nanomaterial biologic activity.

Large-Scale Screening of Nanomaterial Toxicity and Activity

Bethesda , MD | Posted on June 16th, 2008

Reporting its work in the Proceedings of the National Academy of Sciences of the United States of America, a research group lead by Ralph Weissleder, M.D., Ph.D., co-principal investigator of the MIT-Harvard Center of Cancer Nanotechnology Excellence, and Stuart Schreiber, Ph.D., of the Broad Institute of Harvard and MIT, describes its development of a broad panel of in vitro assays that measure a variety of nanoparticle properties. They then use a technique known as hierarchical clustering that identifies nanomaterials that have similar biological effects across a wide range of assays. This approach enabled the investigators to create strong structure-activity relationships that correlate nanoparticle properties to biological activities.

In the experiments reported in this paper, the investigators tested some 50 different nanomaterials. They used four different cell lines for their assays and measured biological activity at four different nanoparticle doses. The large amount of data generated by this type of extensive analysis enabled the researchers to identify different relationships with a high degree of statistical significance. This analysis clearly showed that there were definite correlations between the physical and chemical properties of a nanoparticle and biological activity. More importantly, the investigators found that the relationships identified using in vitro assays correlated with activity observed when the nanoparticles were administered to test animals.

Taking a similar approach, Nicholas Kotov, Ph.D., of the University of Michigan and Yurii Gun'ko, Ph.D., of Trinity College Dublin, led a team of investigators that developed a series of high-content screening assays for use in testing the cytotoxicity of a large number of quantum dots and gold nanoparticles. These assays, the researchers note, enabled them to distinguish subtle differences in cytotoxicity among similar nanomaterials, which should set the stage for conducting multiparametric analyses on large numbers of particles in a rapid and quantitative manner. The investigators are now working to modify their assay protocols to include biological properties such as transport across the cell membrane.

####

About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:


National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © National Cancer Institute

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract - “Perturbational Profiling of Nanomaterial Biologic Activity.”

View abstract - “High-Content Screening as a Universal Tool for Fingerprinting of Cytotoxicity of Nanoparticles.”

Related News Press

News and information

Ag/ZnO-Nanorods Schottky diodes based UV-PDs are fabricated and tested May 26th, 2017

New metamaterial-enhanced MRI technique tested on humans May 26th, 2017

Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017

Unveiling the quantum necklace: Researchers simulate quantum necklace-like structures in superfluids May 26th, 2017

Nanomedicine

New metamaterial-enhanced MRI technique tested on humans May 26th, 2017

Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

Sensors detect disease markers in breath May 19th, 2017

Announcements

Ag/ZnO-Nanorods Schottky diodes based UV-PDs are fabricated and tested May 26th, 2017

New metamaterial-enhanced MRI technique tested on humans May 26th, 2017

Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017

Unveiling the quantum necklace: Researchers simulate quantum necklace-like structures in superfluids May 26th, 2017

Tools

New metamaterial-enhanced MRI technique tested on humans May 26th, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

Nanomechanics, Inc. to Exhibit at the SEM Conference: Nanoindentation experts will attend and exhibit their instruments at the Conference and Exposition on Experimental and Applied Mechanics in Indianapolis May 25th, 2017

Plasmon-powered upconversion nanocrystals for enhanced bioimaging and polarized emission: Plasmonic gold nanorods brighten lanthanide-doped upconversion superdots for improved multiphoton bioimaging contrast and enable polarization-selective nonlinear emissions for novel nanoscal May 19th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project